Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lipella Pharmaceuticals, Inc. ( (LIPO) ) just unveiled an announcement.
On October 3, 2025, Dr. Michael Chancellor announced his retirement from Lipella Pharmaceuticals Inc., where he served as Chief Medical Officer and a Board member, effective December 4, 2025. His retirement is not due to any disagreements with the company’s operations, policies, or practices, suggesting a smooth transition for the company.
The most recent analyst rating on (LIPO) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Lipella Pharmaceuticals, Inc. stock, see the LIPO Stock Forecast page.
More about Lipella Pharmaceuticals, Inc.
Average Trading Volume: 5,498
Technical Sentiment Signal: Hold
Current Market Cap: $2.8M
Learn more about LIPO stock on TipRanks’ Stock Analysis page.